Cas:142851-03-4 Ethyl N-Boc-piperidine-4-carboxylate manufacturer & supplier

We serve Chemical Name:Ethyl N-Boc-piperidine-4-carboxylate CAS:142851-03-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethyl N-Boc-piperidine-4-carboxylate

Chemical Name:Ethyl N-Boc-piperidine-4-carboxylate
CAS.NO:142851-03-4
Synonyms:1-tert-butyl 4-methyl piperidine-1,4-dicarboxylate;4-Methyl 1-(2-methyl-2-propanyl) 1,4-piperidinedicarboxylate;Ethyl N-BOC-4-piperidinecarboxylate;Methyl 1-Boc-4-piperidinecarboxylate;MFCD01763998;Ethyl 1-(tert-Butoxycarbonyl)-4-piperidinecarboxylate;1-Boc-4-piperidinecarboxylic Acid Ethyl Ester;Piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-ethyl ester;Ethyl 1-(tert-Butyloxycarbonyl)isonipecotate;Dimethylethyl piperidinedicarboxylic acid ethyl ester;Ethyl 1-Boc-4-piperidinecarboxylate;4-Ethyl 1-(2-methyl-2-propanyl) 1,4-piperidinedicarboxylate;Methyl N-Boc-piperidine-4-carboxylate;N-Boc-4-Carbethoxy Piperidine;1-Boc-4-piperidinecarboxylic Acid Methyl Ester;Piperidine-1,4-dicarboxylic Acid 1-tert-Butyl 4-Methyl Ester;1-O-tert-butyl 4-O-methyl piperidine-1,4-dicarboxylate;1-(tert-Butoxycarbonyl)-4-piperidinecarboxylic Acid Ethyl Ester;1,4-Piperidinedicarboxylic acid, 1-(1,1-dimethylethyl) 4-ethyl ester;1-tert-Butyl 4-ethyl piperidine-1,4-dicarboxylate;1,4-Piperidinedicarboxylic acid, 1-(1,1-dimethylethyl) 4-methyl ester;1-tert-butyl-4-methylpiperidin-1,4-dicarboxylat;Piperidine-1,4-dicarboxylic Acid 1-tert-Butyl 4-Ethyl Ester;1-(tert-Butoxycarbonyl)-4-piperidinecarboxylic Acid Methyl Ester;1-N-Boc-4-Piperidinecarboxylic acid methyl ester;1-O-tert-butyl 4-O-ethyl piperidine-1,4-dicarboxylate;Methyl 1-(tert-Butoxycarbonyl)-4-piperidinecarboxylate
Molecular Formula:C12H21NO4
Molecular Weight:243.299
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:307.4±35.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.473
PSA:55.84000
Exact Mass:243.147064
LogP:1.51

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 1-tert-butyl 4-methyl piperidine-1,4-dicarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 1-(tert-Butoxycarbonyl)-4-piperidinecarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4-Piperidinedicarboxylic acid, 1-(1,1-dimethylethyl) 4-ethyl ester Use and application,1-(tert-Butoxycarbonyl)-4-piperidinecarboxylic Acid Methyl Ester technical grade,usp/ep/jp grade.


Related News: Innova’s kit includes a nasal swab and a lateral flow test strip, which in less than a half-hour produces colored lines to display a positive reading, similar to a pregnancy test. However, the FDA said that false-negative and false-positive results may lead to delayed diagnoses, inappropriate treatment and the further spread of the virus. Ethyl N-Boc-piperidine-4-carboxylate manufacturer But they’ll be subject to up to 14 days of mandatory quarantine once they’re back in the US. Ethyl N-Boc-piperidine-4-carboxylate supplier Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. Ethyl N-Boc-piperidine-4-carboxylate vendor Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. Ethyl N-Boc-piperidine-4-carboxylate factory First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s.